HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
IDM-1
Description
IDM-1 is IDM’s most advanced antibody-based Cell drug for the treatment of cancer. It is comprised of MAK(Monocytes-derived Activated Killer) cells associated with MDX-210, a bispecific anti-HER-2/neu antibody developed by Medarex Inc.
Company not known
Osidem
